Cargando…
Levels of serum sclerostin, FGF-23, and intact parathyroid hormone in postmenopausal women treated with calcitriol
OBJECTIVE: This study aimed to determine the effect of calcitriol on serum concentrations of fibroblast growth factor-23 (FGF-23), sclerostin, intact parathyroid hormone (PTH), and handgrip strength in postmenopausal women with low bone mass. METHODS: A randomized, double-blind controlled trial was...
Autores principales: | Cheng, Qun, Wu, Xiaoxing, Du, Yanping, Hong, Wei, Tang, Wenjing, Li, Huilin, Chen, Minmin, Zheng, Songbai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247960/ https://www.ncbi.nlm.nih.gov/pubmed/30532527 http://dx.doi.org/10.2147/CIA.S186199 |
Ejemplares similares
-
Parathyroid Hormone Regulates Circulating Levels of Sclerostin and FGF23 in a Primary Hyperparathyroidism Model
por: Nagata, Yuki, et al.
Publicado: (2022) -
FGF-23 and sclerostin in serum and bone of CKD patients
por: Lima, Florence, et al.
Publicado: (2023) -
Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease
por: Brito Galvao, Joao F, et al.
Publicado: (2013) -
Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease
por: Raji, Yemi R, et al.
Publicado: (2022) -
Relationship Between Changes in Serum Levels of Intact Parathyroid Hormone and Sclerostin After a Single Dose of Zoledronic Acid: Results of a Phase 1 Pharmacokinetic Study
por: Kuroda, Tatsuhiko, et al.
Publicado: (2021)